Hepion Pharmaceuticals (HEPA) - price stock, stock chart, quote online, dividends, stock analysis, stock news, company profile

Hepion Pharmaceuticals NASDAQ

HEPA

$1.49 0.0000 0.0000%

Today share price

USA

Sector: Healthcare Industry: Biotechnology

Get access
to the rating of Finrange stocks

With this tariff you will be able to use the service without restrictions, all information will be available

Get 7 days free

7.18M

-7.49M

1.14

4.82M

-54.01 %

Indicator	Company	Industry
P/E (LTM) Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months. More	-0.17	14.85
P/BV (LTM) Shows the ratio of the market price of the share to the current book value. More	0.99	3.70
EV/EBITDA (LTM) Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months. More	0.18	9.67
Net Debt/EBITDA (LTM) A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt. More	0.35	-0.17
ROE (LTM) Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months. More	-583.42	11.19

1.36$ 3.69$

Min Max

Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing CRV431, a cyclophilin inhibitor that is in Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver disease. The company was formerly known as ContraVir Pharmaceuticals, Inc. and changed its name to Hepion Pharmaceuticals, Inc. in July 2019. Hepion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Edison, New Jersey.

Address:

399 Thornall Street, Edison, NJ, United States, 08837

Company name:

Hepion Pharmaceuticals

Issuer ticker: HEPA

ISIN: US4268971045

Country: USA

Exchange: NASDAQ

Currency: $

IPO date: 2014-02-11

Sector: Healthcare

Industry: Biotechnology

Site:

https://www.hepionpharma.com

On which stock exchange are Hepion Pharmaceuticals (HEPA) stocks traded?

Hepion Pharmaceuticals (HEPA) stocks are traded on NASDAQ.

What is the ticker of Hepion Pharmaceuticals stocks (HEPA)?

The stock ticker of Hepion Pharmaceuticals’s stocks or in other words, the code is HEPA. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Hepion Pharmaceuticals (HEPA) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Hepion Pharmaceuticals (HEPA) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are Hepion Pharmaceuticals (HEPA) stocks traded?

Hepion Pharmaceuticals (HEPA) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Hepion Pharmaceuticals (HEPA) stocks today?

The current price of Hepion Pharmaceuticals stocks on 25.04.2024 is 1.49 dollars. per share.

What is the dynamics of Hepion Pharmaceuticals (HEPA) stocks from the beginning of the year?

Hepion Pharmaceuticals (HEPA) quotes have increased by -52.7% from the beginning of the year up to 1.49 dollars. per 1 stocks.

How much did Hepion Pharmaceuticals (HEPA) stocks increase in апреле 2024?

This month Hepion Pharmaceuticals (HEPA) quotes have increased by -36.86% to 1.49 dollars. per share.

How much are Hepion Pharmaceuticals (HEPA) stocks worth?

Today, on October, 25.04.2024 Hepion Pharmaceuticals’s (HEPA) stocks cost 1.49 dollars..

What is the market capitalization of Hepion Pharmaceuticals (HEPA)?

Capitalization is the market value of Hepion Pharmaceuticals (HEPA) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 25.04.2024, the market capitalization of Hepion Pharmaceuticals (HEPA) is estimated at about 7179912 dollars.

Stock chart Hepion Pharmaceuticals

Stock analysis Hepion Pharmaceuticals

Price change Hepion Pharmaceuticals per year

Summary analysis Hepion Pharmaceuticals

Shareholder structure Hepion Pharmaceuticals

Revenue and net income Hepion Pharmaceuticals

Hepion Pharmaceuticals Shares Soar Premarket Ahead of NASH Study Update >HEPA

Hepion Pharmaceuticals Shares Soar Premarket Ahead of NASH Study Update >HEPA

Hepion Pharmaceuticals Gets Fast-Track Designation for NASH Treatment